Description
The Abbott RealTime SARS-COV-2 Assay is a real-time (rt) reverse transcriptase (RT) polymerase chain reaction (PCR) test intended for the qualitative detection of nucleic acids from the SARS-CoV-2 in nasopharyngeal and oropharyngeal swabs from patients who are suspected of COVID-19 by their healthcare provider. Engineered with dual target assay for RdRp and N-genes, it provides a fully automated solution to help laboratories address the urgent need for patient testing during the Coronavirus (COVID-19) pandemic.
Request Information
Features
Dual target assay for RdRp and N-genes
Qualitative detection of nucleic acids from SARS-CoV-2
maxRatio data analysis removes operator subjectivity
Request Information
Specifications
Technology: Qualitative Multiplex real time PCR
Probe Design: Single Stranded Linear Probe
Target Region: Dual Target, RdRp and N-genes
Assay Runtime: Approximately 7 hours
Throughput: 470 patient samples in 24 hours
Specimen type: Nasopharyngeal swabs, Oropharyngeal swabs
Limit of Detection: 100 copies/mL
Specificity: 100%
Results Reporting: Detected / Not Detected
Sample input volume: 0.5 mL
Internal Control (IC): Armored RNA (Pumpkin), Added to each specimen and control
Controls: One negative and one positive control per run
Request Information
